SME Times is powered by   
Search News
Just in:   • Committed to nurture next-gen innovation in 6G technology: Jyotiraditya Scindia  • Europe facing earlier, stronger heatwaves: Climate scientist  • India and Namibia sign two MOUs in fields of health and entrepreneurship  • PM Modi arrives in Delhi after concluding 'productive and successful' 5-nation tour  • ASEAN to keep on consensus, inclusivity: Malaysian official 
Last updated: 13 Oct, 2021  

Vaccine.Thmb.jpg Hindustan Syringes to expand at an outlay of Rs 150 cr

Vaccine.jpg
   Top Stories
» Committed to nurture next-gen innovation in 6G technology: Jyotiraditya Scindia
» Piyush Goyal holds talks with Malaysian minister on review of ASEAN trade pact
» India and OPEC have a unique and symbiotic relationship: Hardeep Puri
» SIP inflows hit all-time high in June, total AUM for equity MF at Rs 74.41 lakh crore
» India set to explore over 2.5 lakh sq kms area in one of largest offshore energy efforts
SME Times News Bureau | 13 Oct, 2021
Medical syringe major Hindustan Syringes and Medical Devices Ltd (HMD) is in the process of expanding its cannulas (needle points) and needle capillary tubing production capacity, said a top company official.

"Our capital expenditure last year was Rs 100 crore and this year, it will be over Rs 50 crore. The total capex will be Rs 150 crore on syringes and on the backward integration," Managing Director Rajiv Nath told IANS.

He said a new 1.5 lakh square feet factory within the existing 11 acre complex at Faridabad (Haryana) will be commissioned by January 2022 to increase capacity from four billion cannulas per annum to six billion per annum.

The capex will be funded internally, Nath added.

On October 11, the company achieved a milestone of supplying 500 million 0.5 ml auto disable (AD) syringes to the government to help vaccinate over 685 million people till date to support the massive vaccination campaign to eradicate Covid-19.

The next lot of 16.3 million syringes has been inspected and is ready to dispatch.

According to Nath, the company is on track to produce and supply outstanding orders of 310 million 0.5 ml Kojak AD syringes by 2022 beginning, hopefully by January end.

He requested the Central government to place orders for syringes with the manufacturers in India well in advance so that the latter could ramp up supplies or allocate supplies for the government.

Nath said with the Central government planning to resume export of surplus Covid-19 vaccines in the fourth quarter of 2021 in order to fulfill the commitment of India towards COVAX, HMD is confident that India will also be in a position to export some syringes as part of 'Vaccine & Syringe Maitri'.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
84.35
82.60
UK Pound
106.35
102.90
Euro
92.50
89.35
Japanese Yen 55.05 53.40
As on 12 Oct, 2024
  Daily Poll
Do you think Indian businesses will be negatively affected by Trump's America First Policy?
 Yes
 No
 Can't Say
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter